At a glance
ClinicalIndex Comparison RecordN/ACompleted· 80 enrolled
Drug / intervention
Progressive Additional Lenses (PAL), pre calibrated and made of polymeric material with anti-reflection coatingdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Assessment of Three Basic Progressive Lens Designs
In Brief
A clinical study evaluating Progressive Additional Lenses (PAL), pre calibrated and made of polymeric material with anti-reflection coating for Presbyopia. Completed, enrolled 80 participants across 1 site.
Detailed Summary
This clinical trial investigates the differences between three different progressive addition lens designs. It is a non-invasive double-masked randomized clinical investigation. For this study, 80 participants will be recruited.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPresbyopia
CountriesUnited States
CollaboratorsHoya Vision Care
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartDec 2021
First PostedFeb 2022
Primary CompletionJun 2022
TodayJul 2026
First PostedFeb 23, 2022
Enrollment StartDec 9, 2021
Primary CompletionJun 6, 2022
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 4.4 years ago
Interventions
Progressive Additional Lenses (PAL), pre calibrated and made of polymeric material with anti-reflection coatingdevice
Subjects will be wearing three different PAL designs with different geometries of the optical progression.